TY - JOUR
T1 - Risk of acquiring Ascaris lumbricoides infection in an endemically infected rural community in Venezuela.
AU - Incani, Renzo Nino
AU - Mughini-Gras, Lapo
AU - Homan, Tobias
AU - Sequera, Ivan
AU - Sequera, Luis
AU - Serrano, Ruth
AU - Sequera, Carlos
AU - Salas, Luis
AU - Salazar, Marisabel
AU - Santos, Paola
N1 - Funding Information:
Financial support was received from the project LOCTI-Universidad de Carabobo N° 1.235 under the
Publisher Copyright:
Copyright © The Author(s), 2022. Published by Cambridge University Press.
PY - 2022/7/29
Y1 - 2022/7/29
N2 - Soil-transmitted helminths, such as
Ascaris lumbricoides, are the most prevalent parasites globally. Optimal anthelmintic treatment for
A. lumbricoides in endemically infected communities is challenged by several host-related and environmental factors influencing infection acquisition. We assessed the risk of
A. lumbricoides (re)infection after treatment in a Venezuelan rural community. Individual merthiolate-iodine-formaldehyde-fixed faecal samples were collected from 224 persons before a single-dose pyrantel treatment and at 1, 3, 6, 9 and 15 months after treatment. Effects of age, sex and socioeconomic status (SES) on
A. lumbricoides prevalence, eggs/gram faeces (EPG) and infection (re)acquisition were assessed using both generalised linear mixed-effects models and survival analysis. Pre-treatment
A. lumbricoides prevalence was 39.7%. Higher prevalence was associated with younger age and lower SES. Higher EPG values were observed among young children. Median time to
A. lumbricoides infection was six months after treatment: at 1, 3, 6, 9 and 15 months post-treatment, cumulative incidence was 6.7%, 18.9%, 34.6%, 42.2%, and 52.6%, respectively. Younger age, lower SES, and pre-treatment
A. lumbricoides infection status showed significantly elevated hazard ratios. Mass drug administration protocols would benefit from considering these factors in selective treatment strategies and possibly more than just annual or biannual treatments in the target population.
AB - Soil-transmitted helminths, such as
Ascaris lumbricoides, are the most prevalent parasites globally. Optimal anthelmintic treatment for
A. lumbricoides in endemically infected communities is challenged by several host-related and environmental factors influencing infection acquisition. We assessed the risk of
A. lumbricoides (re)infection after treatment in a Venezuelan rural community. Individual merthiolate-iodine-formaldehyde-fixed faecal samples were collected from 224 persons before a single-dose pyrantel treatment and at 1, 3, 6, 9 and 15 months after treatment. Effects of age, sex and socioeconomic status (SES) on
A. lumbricoides prevalence, eggs/gram faeces (EPG) and infection (re)acquisition were assessed using both generalised linear mixed-effects models and survival analysis. Pre-treatment
A. lumbricoides prevalence was 39.7%. Higher prevalence was associated with younger age and lower SES. Higher EPG values were observed among young children. Median time to
A. lumbricoides infection was six months after treatment: at 1, 3, 6, 9 and 15 months post-treatment, cumulative incidence was 6.7%, 18.9%, 34.6%, 42.2%, and 52.6%, respectively. Younger age, lower SES, and pre-treatment
A. lumbricoides infection status showed significantly elevated hazard ratios. Mass drug administration protocols would benefit from considering these factors in selective treatment strategies and possibly more than just annual or biannual treatments in the target population.
KW - Animals
KW - Ascariasis/drug therapy
KW - Ascaris lumbricoides
KW - Child
KW - Child, Preschool
KW - Feces/parasitology
KW - Helminthiasis/epidemiology
KW - Humans
KW - Prevalence
KW - Rural Population
KW - Soil/parasitology
KW - Venezuela/epidemiology
KW - risk factors
KW - soil-transmitted helminthiasis
KW - pyrantel
UR - http://www.scopus.com/inward/record.url?scp=85135787579&partnerID=8YFLogxK
U2 - 10.1017/S0950268822001273
DO - 10.1017/S0950268822001273
M3 - Article
C2 - 35983726
SN - 0950-2688
VL - 150
SP - 1
EP - 9
JO - Epidemiology and Infection
JF - Epidemiology and Infection
M1 - e151
ER -